MLYSbenzinga

Mineralys Therapeutics To Present Data From Phase 2 Advance-HTN Trial At 2025 American College of Cardiology's Annual Scientific Session & Expo MAr. 29

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 17, 2025 by benzinga